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Supplementary Materials and Methods 
Generation of the double-stranded RNAs 
DsRNA against the UTR region of BAF155 was transcribed using MEGAscript T7 kit 
(Life technologies) following the manufacturer’s instructions. siRNA used in the study 
was purchased from Qiagen:  Smarcc1_5 (SI04422964) and AllStars Negative 
Control (cat. 1027280). The sequences are listed in Table 1. The concentrations of 
BAF155 transcript used for overexpression and rescue experiments are 2,0 μg/μl 
and 1.5 μg/μl respectively. 
Table S1: Oligonucleotides used in RNAi experiments 
Image acquisition and processing using Object Scan plugin for Fiji. 
Z stacks were densely scanned to obtain at least thirty images at intervals 
ranging from 0.5 µm to 3µm to ensure that the data from the full embryo was 
captured. Analysis of images and generation of image projections were performed in 
Fiji ImageJ. The fluorescence intensities in all planes of each Z stack were quantified 
using the Object Scan plugin for ImageJ (developed by Richard Butler, available on 
request). Processing by Object Scan was applied to a densely scanned Z-stack 
where the objects (nuclei) were identified by patch sampling to detect intensity edges 
based on local gradients, The objects then generated two-dimensional masks, which 
were clustered in three dimensions to define the final object map for analysis. The 
Object Scan plugin was used to identify cells in 3D image stacks of embryos to map 
nuclei based on DAPI labelling and then automatically measure fluorescence 
intensity in the channels of interest in each nuclei of an embryo. The fluorescence 
intensity obtained from each channel was then normalised to the intensity in the 
main channel (DAPI). The normalised values were then used for further analysis. 
Object Scan plugin is available on request from R. Butler rsb48@cam.ac.uk 
 
 
dsRNA against 
BAF155 
FW taatacgactcactatagggccttctcccggagtccta 
RE taatacgactcactatagggcctcacaaaactggatgggt 
dsRNA against 
GFP 
FW taatacgactcactatagggacgtaaacggccacaagtt 
RE taatacgactcactatagggtgttctgctggtagtggtcg 
Smarcc1_5 SI04422964 acgcatcctggtttgattata 
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Immunofluorescence staining 
Embryos and cells were fixed for 10 min in 4% paraformaldehyde at 37°C and rinsed 
twice in PBS 0.2% Tween (PBT). Permeablisation was carried out for 20 min in 0.5% 
Triton X, followed by the 3 washes in 1x PBT. Blocking was performed in 3% BSA 1x 
PBT for 1 hour at 37°C. Primary antibodies incubations were performed at 4°C 
overnight, followed by washes 3 times in PBT before detection using secondary 
antibodies and DAPI counterstain for 2 h at room temperature. The list of primary 
antibodies used in this study is listed in Table 2. The secondary antibodies were 
conjugated with Alexa 488, Alexa 568 or Alexa 647 (Invitrogen) and had minimal 
cross reactivity to other species.  
Table S2. Primary antibodies  
Protein target Host species Source, cat no Dilution  
BRG1 Rabbit Santa Cruz Biotechnology, 
sc10768 
1:50 
BRG1 Mouse Santa Cruz Biotechnology, 
sc17796 
1:200 
BAF57 Goat Abcam, ab14764 1:50 
HA 
(Hemagglutinin) 
Rat Roche 11867423001 
 
1:100 
HA 
(Hemagglutinin) 
Mouse Covance, clone 16B12 1:100 
BAF155 Rabbit Home-made, clone 7 1:200 
Methyl-BAF155 Rabbit A gift from W.Xu lab 1:200 
SOX17 Goat R&D, AF1924 1:200 
CDX2 Mouse Biogenex, clone CDX2-88 1:200 
NANOG Rabbit Abcam, ab 80892 1:200 
NANOG Rat eBioscience, 14-5761-80 1:100 
CENPA Rabbit Cell Signalling, C51A7 1:200 
OCT4 Mouse Santa Cruz Biotechnology, C-10 1:200 
TROMA1 Rat A gift from R. Kemler lab 1:50 
RFP Rabbit Abcam, ab62341 1:100 
H2A Rabbit Abcam, ab18255 1:100 
H3K9me3 Mouse Cell Signalling, 5327 1:100 
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Histone R17me2 Rabbit Abcam, ab8284 1:100 
 
The proximity ligation assay (PLA) 
The PLA was performed using Duolink assay reagents (Sigma, cat no. 
DUO92102, DUO92013, DUO92006, DUO92003) on 60-well MicroWell plates 
(Thermo scientific. cat no 439225) in 10 µl droplets covered in with mineral oil 
(Sigma, cat. no. M8410). The stages prior to recognition with PLA probes were 
performed exactly as for the immunofluorescence staining.  Recognition with PLA 
probes was performed using 2 µl of each PLA probes diluted in 6 µl of 3% BSA 1x 
PBS per 10µl reaction for 1h at 37 ºC. The PLA-probes combinations were selected 
corresponding to the antibodies used in each assay depending on the host species 
of the antibodies used. Ligation of the short oligonucleotide sequences attached to 
the PLA probes was performed using 7 µl of DEPC water supplemented with 2 µl of 
the 5x ligation buffer and 1µl of ligase per a 10 µl reaction (Sigma, DUO92102) for 
30 min at 37 ºC. Amplification of the circular DNA formed after the ligation step was 
achieved using 7.5 µl of DEPC water supplemented with 2 µl of the 5x Amplification 
stock and 0.5µl of ligase per a 10 µl reaction (Sigma, DUO92102) for 3 h at 37 ºC in 
the dark. The washes after the PLA procedure were performed 1x and 0.01x 
Washing Buffer B (Sigma, cat no DUO82049) for 5 min each in 10 µl drops. 
Additional antibody staining after the PLA procedure was performed by transferring 
the embryos into 3% BSA 1x PBS solution supplemented with the primary antibodies 
required, and incubation at 4 ºC overnight. The detection with secondary antibodies 
and counterstaining with DAPI was performed as previously described for the 
immunofluorescence staining procedure. 
Table S3. RT-QPCR primers 
RT-qPCR primers 
Gene name Sequence 
SRG3 (BAF155)-F ACCATCAGATGCCGCCACCC 
SRG3 (BAF155)-R GCTGCCACAGCGGGGATCAT 
BRG1-F TCAAGGATGATGCCGAGGTG 
BRG1-R GCCACTGCTTCTCTGTCAGT 
SMARCE1 (BAF57)-F CAAGCGACAGGTCCAGTCTT 
SMARCE1 (BAF57)-R AAGGAGTCCGTGCTTTCCAG 
SMARCB1 (INI1)-F GCTCCGAGGTGGGAAACTAC 
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SMARCB1 (INI1)-R TGATCATGTGACGATGCCACT 
ARID1A-F TCAGCCGTATGGTGGGACTA 
ARID1A-R TACCCATGTCCTTGTTGCGG 
GAPDH-F AGAGACGGCCGCATCTTC 
GAPDH-R CCCAATACGGCCAAATCCGT 
NANOG-F GGTTGAAGACTAGCAATGGTCTGA 
NANOG-R TGCAATGGATGCTGGGATACTC 
OCT 4-F TTGGGCTAGAGAAGGATGTGGTT 
OCT 4-R GGAAAAGGGACTGAGTAGAGTGTGG 
SOX17-F CATGGATACAATGAGCAGCACC 
SOX17-R GACCCTTGGGGAAAACTGGC 
GATA 6-F CTCAGGGGTAGGGGCATCAG 
GATA 6-R AGAGGCCGTCTTGACCTGAA 
CDX2-F AAACCTGTGCGAGTGGATG 
CDX2-R TCTGTGTACACCACCCGGTA 
Cell culture 
ESC were cultured in DMEM (GIBCO) media supplemented with 15% FCS (Sigma); 
TS cells were grown in RPMI (Sigma) supplemented with 20% FCS (Sigma), the 
cells were a kind gift from A. Surani’s lab. All culture media solutions were 
supplemented with 2 mM L-glutamine (GIBCO), 1 mM sodium pyruvate (GIBCO), 
penicillin 50 units/ml/streptomycin 50 μg/ml (GIBCO), 1 × NEAA (GIBCO), and 
100 mM β-mercaptoethanol. ESC cells medium was supplemented with either with 
LIF or 2i LIF; TS cells media was supplemented with heparin (Sigma) and FGF4 
(R&D systems). Cells were cultured at 37°C and 5% CO2. Prior to fixation 
procedures, the cells were plated onto on μ plates (Ibidi) at equal densities and 
cultured overnight. 
Generation Nanog-YFP transgenic mouse line. 
The COOH terminus of the Nanog protein was tagged with YFP fluorescent protein 
using BAC based recombineering /gene targeting methods. To generate BACs with 
a tagged Nanog allele, the cells were electroporated with a tagging cassette YFP-
Em7-T2A-BlasticidineR that was PCR amplified using two primers: NanogYFP-F 
containing 50bp homology to the 3’-end of the Nanog ORF (excluding stop codon) 
and NanogYFP-R containing 50bp homology to the 5’ end of Nanog 3’UTR 
(including ORF stop codon). To generate targeting plasmids, the cells carrying 
tagged BACs were electroporated with a Gap-repair plasmid that was PCR amplified 
using primers: NanogYFP-5’ and Nanog-YFP-3’ containing 50bp homology to the 
mouse genome sequence approximately 5kbp upstream and downstream of Nanog 
targeting site, respectively. The construct was linearized with AsiSI and 
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electroporated into E14 ES cells. Blasticidine-resistant colonies were screened for 
homologous recombination into Nanog allele by long range PCR and followed by 
sequencing. Chimeric mice were generated by blastocyst injection of ES cells 
containing tagged Nanog allele. These were crossed to C57Bl6 mice to obtain 
heterozygous transgenic offspring. Presence of the YFP tag was confirmed by PCR. 
Primer sequences used are listed in Table 5.  
Table S4. Primer sequences used for Nanog-YFP line generation. 
N
a
n
o
g
-Y
F
P
 FW aagccttggaattattcctgaactactctgtgactccaccaggtgaaatagtgagcaagggcgaggagct 
RE ggaaggaacctggctttgccctgactttaagcccagatgttgcgtaagtcttagccctcccacacataac 
5’ tctagcaaataagtagacagccctgaaagcagcttctaaatggaaaattatcctgtgtgaaattgttatccgc 
3’ gtcccttaacccacaggctttatgcttatgttaaaatatcttagatgttgccactggccgtcgttttaca 
 
Single embryo genotyping by PCR  
Embryos from heterozygous intercrosses were treated in 200 μG/mL Proteinase K in 
CoralRed PCR buffer (QIAGEN) at 55°C for one hour, followed by a 5-minute 
incubation at 95°C.  Primers listed in Table 5 were used to distinguish embryo 
genotypes in the PCR reactions using the Fast Cycling PCR kit (QIAGEN). The PCR 
products were analyzed in 2.2% agarose gels.  
Table S5. The primers used for genotyping of transgenic mice: 
YFP FW gcagtgcttcgcccgctaccc- 
RE tctcgttggggtctttgctcag 
Srg3 KO 5′ primer P1 ACAACGAAATCTGTGGAGTAGC 
KO Srg3-specific 3′ 
primer P2 
GGGATGGGTTCTGAAGATCA 
 
KO Neo-specific 3′ 
primer P3 
CTAAAGCGCATGCTCCAGAC 
 
CARM1 Oligo 1 AGTTGGTGACCCTTGTGTCC 
 Oligo 2 AGCTGCCAGGACCTCTGATA 
 Oligo 3 CCTGAGGCAGAAAACAGTATGA 
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FRAP data acquisition and analysis 
Prior to the photobleaching experiments, we placed each embryo in a single well of a 
polystyrene grid to prevent movement, set the temperature of the microscope 
chamber to 37 oC, and the level of CO2 in the chamber was maintained at 5% at all 
times to allow the normal embryonic development. The recovery curves were 
obtained by measuring intensities of background, control region and photobleached 
region in a 18-μm2 rectangular region using Leica FRAP Wizard Software for Leica 
SP5 with resonant scanner. Details on the setting of photobleaching are listed in the 
Table 6. For each experiment at least 10 recovery curves from at least 10 embryos 
were taken for each described condition. Each replicate value in each dataset was 
considered an individual point for curve fitting. The analysis of the FRAP data 
obtained was performed using GraphPad Prism software 
(http://www.graphpad.com/) for nonlinear fitting and plotting on graphs. The recovery 
was fitted to a biexponential of the form f(t)=1-Fim-A1 × e-t/T fast-A2 × e –t/T slow (Eq. 1) 
and to a single exponential of the form f(t)=1- Fim- A1 × × e-t/T fast  (Eq.2),  where Fim is 
a size of the immobile pool of the protein, T fast and T slow are the half times, and A1 
and A2 are the amplitudes of the fast and slow components of the recovery. An F-
test was used to choose the equation and compare datasets. The maximum 
recovery value was used to establish the ratio of immobile and mobile protein in the 
nucleus. We estimated the levels of immobile protein as total protein level (intensity 
of the signal prior to bleaching) minus the fraction that recovered in FRAP, which 
represents the mobile fraction of the protein. 
Table S6. Photobleaching settings used in the FRAP experiments. 
Method of bleaching Set 
background to 
zero 
Lasers 
495,514,561 
ON to 100% 
Fly mode 
 Pre-bleach Bleach Post-bleach 1 Post-bleach 2 
Frames 4 20 50 25 
t/frame [s] 0.139 0.139 0.139 1.546 
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Figure S1, related to Figure 1. BAF170 expression in the late pre-implantation 
blastocyst; and controls experiments confirming the specificity of PLA.  (A) 
BAF170 is not expressed at E4.5 stage (N=4). (B) Omission of BRG1 antibody 
results in loss of the fluorescence signal. (C) Depletion of BAF155 result in a weak 
fluorescent signal through BAF155-BRG1 PLA. (D) CENPA is expressed in all cells 
of the pre-implantation blastocyst. (D’) The interaction between CENPA and BRG1 
does not generate fluorescent signal by PLA. (E-E’) H2A and H3K9me3 are present 
in all cells of the pre-implantation blastocyst (N=8 each). (E’’) The interaction 
between H2A and H3K9me3 detected by PLA generated similar fluorescent intensity 
in the cells of a late pre-implantation blastocyst (N=6). 
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Figure S2, related to Figure 2. BAF155 subunit regulates the amount of BAF 
complex in the early embryo. (A) The extent of BAF155 overexpression was 
confirmed by immunofluorescence staining (N=8 each). (B) The quantification of the 
fluorescence intensities of embryos clonally overexpressing BAF155 and BAF57 
(P˂0.001, Students t-test). (C-D) The fluorescence intensity of BRG1 and BAF155 
remained unchanged upon BAF57 (C) or Ruby (D) over-expression (P˃0.05, 
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Student’s t-test). (E) HA-tagged BAF155 or CENPA mRNA were injected into one 
blastomere of a 2-cell stage and analysed at 4-cell stage. (F) The expression of 
exogenous BAF155 and CENPA was detected by immunofluorescence in a half of a 
4-cell stage embryo. (G-G’’) HA-tag of the exogenous BAF155 was found to interact 
with the endogenous BRG1 (G’’), unlike the technical control (G), or the negative 
biological control, HA-tagged CENPA (G’).  
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Figure S3, related to Figure 3. Depletion of BAF155 results in the embryonic 
arrest prior to implantation. (A) Expression of Cdx2+ and Sox17+ cells was not 
affected by BAF155 depletion (dsBAF155 embryos) compared to control (B) 
Depletion of BAF155 by dsRNA has lead to a slight reduction in total cell number 
(76±7 cells) compared to the control (88±4 cells), and increase in  the number of 
Nanog+ cells (17 cells±4) compared to control (9 cells±3). The increase in Nanog+ 
cells happens due to Nanog expression in TE cells in BAF155KD (8 cells±3) in 
BAF155KD, which rarely happens in controls (1 cells±2). (C) RT-qPCR analysis of 
control blastocysts and blastocyst injected with siRNA: transcripts of pluripotency 
markers Nanog and Oct4 were upregulated. (D-E) Down-regulation of BAF155 using 
siRNA leads to an increase of number of Nanog+ cells (P<0.01) and decreased cell 
number (P<0.05, Students t-test).  
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Figure S4, related to Figure 4. Embryonic arrest of BAF155-overexpressing 
embryos during the time of lineage specification (E3.5-E4.5 transition).  The live 
imaging of CAG-GFP embryos (membrane marker), injected with Cherry-tagged 
BAF155 construct were imaged from 8-cell stage until E4.5 stage (N=10). Direct 
comparison of embryonic development of control embryos injected with fluorescent 
marker Ruby (N=6), detected no effect on embryonic development of BAF155OE 
embryos at the 8-cell stage or 16-32 cell stage. The major defects to development 
that lead to arrest of BAF155-overexpressing embryos happen at the E3.5-E4.5 
transition. The arrows mark dying cells in both ICM and TE, determined by position. 
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Figure S5, related to Figure 5. FRAP measurements and controls on mouse 
embryos. (A) The interaction of Cherry-tagged BAF155 and BAF57 with the 
endogenous BRG1 was confirmed by PLA (dotted line). (B) Prior to FRAP 
experiments sample embryos at the 4-8 cell transition from the experimental 
(injected with dsBAF155) and control (injected with dsGFP) were 
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immunofluorescently labelled to check whether BAF155 depletion was sufficient. 
Both groups were co-injected with GAP-GFP fluorescence marker for detection. (C) 
Sample embryos previously injected with either BAF155-HA (experimental) or GAP-
GFP (control) undergoing 4-8 cell transition were subjected to immunofluorescence 
with HA antibody to confirm the over-expression. (D-G) The measurements of 
recovery kinetics of BAF57 and CENPA upon BAF155 depletion (D-E) and BAF155 
overexpression (F-G) were estimated by measuring the fluorescence intensity in 
rectangular regions of nuclei prior to photobleaching (P) and for 40s after 
photobleaching (0s) 
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Figure S6, related to Figure 6 Generation and validation of NANOG-YFP 
reporter mouse. (A) The NANOG-YFP transgenic mouse line was generated by a 
direct knock-in of YFP open-reading frame into NANOG gene locus. The resulting 
protein product is NANOG protein fused to YFP. (B) Snapshots from a time-lapse 
imaging showing a developing Nanog-YFP pre-implantation embryo in which Nanog 
expression becomes localised to EPI (N=7) (C) Immunofluorescent staining showing 
that YFP protein exactly corresponds to the endogenous Nanog protein localization.  
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Figure S7, related to Figure 7. CARM1-mediated regulation methylation of 
BAF155. (A) The quantification of meBAF155 expression at E3.5. (B) The 
quantification of meBAF155 expression at E4.5. (C) The quantification of 
fluorescence intensity of H3R17me2 expression at E3.5. (D) The embryos cultured 
from zygote stage in 7.1 μM arrested at the transition to the 2-cell stage, while the 
embryos in the equal concentration of DMSO progressed normally to the blastocyst. 
(D) The effect of CARMi titration on the pre-implantation development of embryos 
cultured in the inhibitor from the late 2-cell stage: At 7.1μM the embryos progress to 
the normal hatching blastocysts in the majority of cases (95.5%, N=22). At 9μM only 
73% hatch (N=22) compared to 94.2% (N=34) in DMSO (non-hatching blastocysts 
are marked by arrows); at CARMi concentration of 28.4 μM embryos arrested at 4-8 
transition (N=16).  
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Movie 1. BAF155-overexpressing embryos arrest during the time of lineage 
specification (E3.5-E4.5 transition).   
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Movie 2. Control embryos injected with Ruby develop normally until late pre-
implantation stages. 
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Movie 3. Time-lapse imaging showing a developing Nanog-YFP pre-
implantation embryo in which Nanog expression becomes localised to EPI. 
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